|
|
Product trade name: Huminsulin Basal NPH Pen
| Pharmaceutical active ingredients: |
| Insulin Isophane Injection Human, prb |
| Available forms, composition and doses of Huminsulin Basal NPH Pen: |
| Injectable; Injection; Insulin Isophane Injection Human, prb 100 IU / mlInjectable; Injection; Insulin Isophane Injection Human, prb 40 IU / ml |
| Huminsulin Basal NPH Pen medical category: |
| Human:Insulin preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10AB01 - Insulin (Human)A10AC01 - Insulin (Human)A10AD01 - Insulin (Human)A10AE01 - Insulin (Human)A10AF01 - Insulin (Human) |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Eli Lilly |
Pharmaceutical drugs, medications and other health products with similar to Huminsulin Basal NPH Pen trade names:
Compare some medical and health care products with the same or related to Huminsulin Basal NPH Pen active ingredients:
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Human Insulatard | Insulin Isophane Injection Human, ge | Novo Nordisk; Sanofi-Aventis | | Insulatard Human | Insulin Isophane Injection Human, ge | Novo Nordisk; Sanofi-Aventis | | Berlinsulin H Basal | Insulin Isophane Injection Human, prb | Berlin-Chemie | | Huminsulin Basal | Insulin Isophane Injection Human, prb | Eli Lilly | | Huminsulin Basal NPH | Insulin Isophane Injection Human, prb | Eli Lilly | | Humulina NPH | Insulin Isophane Injection Human, prb | Eli Lilly | | Lillypen Protamine Isophane | Insulin Isophane Injection Human, prb | Eli Lilly | | Umuline Protamine Isophane NPH | Insulin Isophane Injection Human, prb | Eli Lilly | | Huminsulin Profil I | Insulin Isophane Injection Human, prb; Insulin Neutral Injection Human, prb | Eli Lilly | | Huminsulin Profil II | Insulin Isophane Injection Human, prb; Insulin Neutral Injection Human, prb | Eli Lilly |
More pharmaceutical products manufactured or supplied by the same as Huminsulin Basal NPH Pen and similar pharmaceutical companies:
|
|